Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Inj. Adalimumab 40 Mg 0.8 Ml Pfs
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106518721 |
|
Reference Number |
H2242136A |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | - |
| Place | Mumbai CST |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/112024/106518721/viewNitPdf_4765746.pdf |
| Start Date | November 06, 2024 22:12 |
| End Date |
Expired
13/11/2024
Expired 703 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Inj hydroxy progesterone caproate 250 mg 1 ml pfs.
Inj hydroxy progesterone caproate 250 mg 1 ml pfs.
Read moreGtl_medical_ph.no.23012_medicine_triamcinolone 40 mg/ ml - 1 ml inj.
Gtl_medical_ph.no.23012_medicine_triamcinolone 40 mg/ ml - 1 ml inj.
Read moreInj. tirzepatide 10 mg/0.6 ml in multidose penfill pfs
Inj. tirzepatide 10 mg/0.6 ml in multidose penfill pfs
Read moreInj tirzepatide 5 mg/0.6ml, pfs of 2.4 ml,nerivio device
Inj tirzepatide 5 mg/0.6ml, pfs of 2.4 ml,nerivio device
Read moreHyaluronic acid 40 mg + sorbitol 80 mg per ml, 2 ml inj.
Hyaluronic acid 40 mg + sorbitol 80 mg per ml, 2 ml inj.
Read moreInj tirzepatide 2.5 mg,inj tirzepatide 5 mg,inj tirzepatide7. 5 mg,inj tirzepatide 10 mg,tab acalabrutinib 100 mg,tab niraparib 100 mg,inj insulin aspart analogue rapid acting 100 iuperml 3 ml pfs,inj tislelizumab 100 mg 10 ml vial
Inj tirzepatide 2.5 mg,inj tirzepatide 5 mg,inj tirzepatide7. 5 mg,inj tirzepatide 10 mg,tab acalabrutinib 100 mg,tab niraparib 100 mg,inj insulin aspart analogue rapid acting 100 iuperml 3 ml pfs,inj tislelizumab 100 mg 10 ml vial
Read moreof your Industry type